Received May 11, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TD | TD ADSORBED (TENIVAC) | SANOFI PASTEUR | UNK | U8021BA | IM |
expired TENIVAC was administered to a patient with no AE; Initial information received on 24-Apr-2026 regarding an unsolicited valid non-serious case received from other healthcare professional. This case involves a 22-year-old female patient who received an expired diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [Tenivac] with no adverse event. The patient's past medical history, past drugs, vaccination(s), family history, and concomitant medications were not provided. On 24-Apr-2026, the patient received 0.5 mL (booster dose) of an expired diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult suspension for injection (batch: U8021BA, expiry: 16-Mar-2026) (strength: standard) via intramuscular route in an deltoid NOS (not otherwise specified) for immunization with no reported adverse event (Expired product administered, and latency: same day). It was reported that, Treatment = NO TREATMENT and List concomitant: NO OTHER IMMUNIZATIONS. Action taken: Not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.